BRAF-V600E DEGRADATION AS A THERAPEUTIC STRATEGY IN BRAF-V600E MUTANT GLIOMAS

被引：0
|
作者：
Zhao, Guisheng [1 ]
Muldoon, Daniel [1 ]
Mo, Xiulei [2 ]
Tang, Cong [2 ]
Fu, Haian [2 ]
Gustafson, W. Clay [3 ]
Weiss, William A. [3 ]
Nicolaides, Theodore [1 ]
机构：
[1] New York Univ Langone Hlth, Dept Pediat, New York, NY USA
[2] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA
[3] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
THER-17
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [31] SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis
    Tong, Kevin
    Kothari, Om A.
    Haro, Katherine S.
    Panda, Anshuman
    Bandari, Manisha M.
    Carrick, Jillian N.
    Hur, Joseph J.
    Zhang, Lanjing
    Chan, Chang S.
    Xing, Jinchuan
    Gatza, Michael L.
    Ganesan, Shridar
    Verzi, Michael P.
    ONCOGENE, 2021, 40 (41) : 6034 - 6048
  • [32] Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma
    Krepler, Clemens
    Xiao, Min
    Samanta, Minu
    Vultur, Adina
    Chen, Hsin-Yi
    Brafford, Patricia
    Reyes-Uribe, Patricia I.
    Halloran, Molly
    Chen, Thomas
    He, Xu
    Hristova, Denitsa
    Liu, Qin
    Samatar, Ahmed A.
    Davies, Michael A.
    Nathanson, Katherine L.
    Fukunaga-Kalabis, Mizuho
    Herlyn, Meenhard
    Villanueva, Jessie
    ONCOTARGET, 2016, 7 (44) : 71211 - 71222
  • [33] Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region (PTPR)
    Cimino, Patrick
    Corbo, Joseph
    Perry, Arie
    Dahiya, Sonika
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 606 - 606
  • [34] Low-Dose BRAF-Inhibitors in the Treatment of Histiocytic Disorders with the BRAF-V600E Mutation
    Ruan, Gordon
    Goyal, Gaurav
    Abeykoon, Jithma P.
    Bennani, N. Nora
    Rech, Karen
    Young, Jason
    Shah, Mithun Vinod
    Go, Ronald S.
    BLOOD, 2019, 134
  • [35] Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR
    Reid, Anna L.
    Freeman, James B.
    Millward, Michael
    Ziman, Melanie
    Gray, Elin S.
    CLINICAL BIOCHEMISTRY, 2015, 48 (15) : 999 - 1002
  • [36] BRAF-V600E Advanced Lung Adenocarcinoma with Leptomeningeal (LM) Disease Treated with Vemurafenib
    Fernandes, Maria Gabriela
    Costa, Jose
    Reis, Joana
    Jacob, Maria
    Moura, Conceicao
    Machado, Jose
    Hespanhol, Venceslau
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S274 - S275
  • [37] BRAF-V600E immunohistochemistry in a large series of glial and glial-neuronal tumors
    Breton, Quentin
    Plouhinec, Helene
    Prunier-Mirebeau, Delphine
    Boisselier, Blandine
    Michalak, Sophie
    Menei, Philippe
    Rousseau, Audrey
    BRAIN AND BEHAVIOR, 2017, 7 (03):
  • [38] Prognostic impact of BRAF-V600E expression and correlation with mutation status in cutaneous melanoma
    Hugdahl, Emilia
    Kalvenes, May Britt
    Puntervill, Hanne
    Ladstein, Rita
    Akslen, Lars A.
    CANCER RESEARCH, 2016, 76
  • [39] Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastoma
    Li, Wen
    Li, Yang
    Liu, Xiaoling
    Wang, Li
    Chen, Wenqian
    Qian, Xueshen
    Zheng, Xianglong
    Chen, Jiang
    Liu, Yiming
    Lin, Lisong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [40] BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
    Del Bufalo, Francesca
    Ceglie, Giulia
    Cacchione, Antonella
    Alessi, Iside
    Colafati, Giovanna Stefania
    Carai, Andrea
    Diomedi-Camassei, Francesca
    De Billy, Emmanuel
    Agolini, Emanuele
    Mastronuzzi, Angela
    Locatelli, Franco
    FRONTIERS IN ONCOLOGY, 2018, 8
12345